The RFBL Flexi Pack IPO is a closed SME Mainboard offer (Fresh capital only) that opened on 12 May 2026. The RFBL Flexi Pack IPO closed on 14 May 2026, with an issue price of ₹50 per share. The RFBL Flexi Pack IPO has a face value of ₹10 and a lot size of 3,000 shares. The RFBL Flexi Pack IPO is listed on 19 May 2026. The RFBL Flexi Pack IPO allotment was scheduled for 15 May 2026.
On the financial front, the RFBL Flexi Pack IPO reported revenue of ₹70 crore for 30 Sep 2025, compared with ₹135 crore for 31 Mar 2025. The RFBL Flexi Pack IPO PAT was ₹4 crore against ₹8 crore. The RFBL Flexi Pack IPO EBITDA stood at ₹6 crore with a 8.55% margin. The RFBL Flexi Pack IPO net worth as of 30 Sep 2025 was ₹22 crore.
Always verify The RFBL Flexi Pack IPO details and GMP data with the official offer document before investing in the RFBL Flexi Pack IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Sep 2025
31 Mar 2025
31 Mar 2024
Total Assets
52
47
22
Revenue
70
135
80
PAT
4
8
6
EBITDA
6
13
9
Net Worth
22
18
10
Reserves
6
17
8
Total Borrowing
18
19
5
RFBL Flexi Pack IPO Financials FAQs
Revenue of RFBL Flexi Pack (Amount in ₹ Crore) — 30 Sep 2025: 70; 31 Mar 2025: 135; 31 Mar 2024: 80. Profit after tax (PAT) — 30 Sep 2025: 4; 31 Mar 2025: 8; 31 Mar 2024: 6.
EBITDA of RFBL Flexi Pack (Amount in ₹ Crore) — 30 Sep 2025: 6; 31 Mar 2025: 13; 31 Mar 2024: 9. The EBITDA margin is 8.55%.
Total assets — 30 Sep 2025: 52; 31 Mar 2025: 47; 31 Mar 2024: 22. Net worth — 30 Sep 2025: 22; 31 Mar 2025: 18; 31 Mar 2024: 10. Reserves & surplus — 30 Sep 2025: 6; 31 Mar 2025: 17; 31 Mar 2024: 8. (Amount in ₹ Crore)
Total borrowing of RFBL Flexi Pack (Amount in ₹ Crore) — 30 Sep 2025: 18; 31 Mar 2025: 19; 31 Mar 2024: 5. Debt-to-equity ratio: 0.80.
The financials shown for RFBL Flexi Pack IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
